A new formal definition of CKM syndrome from the American Heart Association reflects the strong interplay among metabolic risk factors, chronic kidney disease, and the cardiovascular system.
The large OPT-BIRISK trial adds important information to the complex puzzle of antithrombotic therapy after PCI for acute coronary syndrome, says one expert.
Shared decision making using a novel clinical-decision support tool led to a reduced risk for hypoglycemic events in a prospective study of 94 high-risk elderly people with type 2 diabetes.